Brought to you by WBIW News and Network Indiana
Last updated on Wednesday, August 19, 2009
(INDIANAPOLIS, IN) - Indianapolis-based Eli Lilly is stopping development of an osteoporosis drug.
The pharmaceutical-maker says a study has shown Arzoxifene met its primary objectives, but the results did not indicate the drug would "represent a meaningful advancement in the treatment of osteoporosis."
1340 AM WBIW welcomes comments and suggestions by calling 812.277.1340 during normal business hours or by email at comments@wbiw.com
© Ad-Venture Media, Inc. All Rights Reserved.